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Abstract: The data contained in the follow-up studies of surgical
series should ideally be reported in such a way that they are
comparable from one follow-up study to another and amenable to
amalgamation to draw statistically robust inferences. The authors
provide an analysis of 51 reports of pulmonary metastasectomy for
colorectal cancer to illustrate the problem. It is in the nature of
follow-up studies that data are more plentiful where they concern
explicit descriptors of the patient when assessed for surgery and the
conduct of the operation itself. Data may be sparse in other respects,
because although of interest in a subsequent analysis of outcome,
they were not of direct clinical importance at the time of surgery and
so were not recorded. The authors cannot surmise about unrecorded
data or use them in any analysis. The authors constructed a “wish-
list” of items and tested the 51 publications against it. They also
suggest that the form in which data are presented should include data
summaries, which can be amalgamated. For example, means can be
aggregated, provided the numerator is known, but medians cannot.
In an ideal world, anonymized patient-level data should be retained
and remain accessible for future researchers, but there are substantial
obstacles for saving and sharing data of this kind. A check list for
reports of pulmonary metastasectomy series is offered as a template.
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In the future, we may be sure that decisions about theappropriateness of surgical interventions will be based in-
creasingly on the evidence amalgamated by health services
researchers rather than on professional opinion alone. Sys-
tematic and even-handed searches of the literature to elimi-
nate any bias in what is chosen for citation is central to that
process.1 Extraction of data should also be systematic, as will
be the ways in which data are evaluated and presented. For
this purpose, internationally agreed reporting standards have
been published recently under the acronym Preferred Report-
ing Items for Systematic reviews and Meta-Analyses.2,3
Experience of working with surgical reports of metas-
tasectomy shifts the problem a stage back: the quality of what
comes out in systematic reviews is limited by the quality of
what goes in. After setting criteria for inclusion in the
systematic reviews, the authors of existing systematic re-
views of hepatic and pulmonary metastasectomy for patients
with colorectal cancer reported that many articles were not of
sufficient quality to be included in the reviews.4,5 Although
having severely restricted on quality grounds the number of
articles to be included (20 for pulmonary metastasectomy5
and 30/529 for hepatic metastasectomy), the authors of these
articles were unable to present meta-analysis and relied
largely on textual summaries of the articles.4,5 This represents
a large loss of clinical data, not to mention the time of the
authors, reviewers, and editors if data cannot be used to guide
future practice.
The authors, while working with others on a systematic
review6 with a wider remit, similarly noted that there was a
lack of uniformity in the data elements reported, and that
there was a variation in the way in which data were presented
and summarized. We took the opportunity to categorize the
problems in data reporting with the objective of suggesting
improvements. Reporting of data in a consistent and compre-
hensive way would allow readers to compare their own
cohort of patients with published results.
METHODS
The articles were selected for the systematic review
from a formal search strategy (detailed in the appendix of the
report6) and were searched for specified data elements (Table 1).
We identified commonly reported data elements and added
some, which we would like to have found, in the articles
reporting metastasectomy.
We identified what useable data under these headings
were available in each of the 51 clinical reports. We then
considered whether the way in which the data were presented
made their aggregation or use in a data synthesis possible.
RESULTS
No patient-level data were available in the articles, and
there was no indication that these data were available and
could be provided to other researchers. Figure 1 is a summary
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of the presence of data elements in the article as presented in
the systematic review and quantitative synthesis.6
These studies, possibly with a few exceptions, were
based on case note (chart) review. It is inevitable that routine
data recorded before and at the time of a hospital admission
for surgery can be recovered, whereas other information
(symptomatic status, for example, or measurements of lung
function) can be never recovered unless they were recorded at
the time. Only fit and usually asymptomatic patients are
considered for pulmonary metastasectomy, so lung function,
for example, may not have been a clinically required mea-
surement. The data available are, thus, more complete for
surgical “facts” than for functional status.
The number of patients, their age and sex, and the start
date of the surgical series were nearly always reported. Age
was also reported in some way in 44 of 51 reports. Most
articles (38 of 51) reported an age range. Otherwise age was
inconsistently reported: mean 23 of 51, median 17 of 51, and
some gave both. The standard deviation was given in only
seven articles. One article7 reported age in intervals (50
years, 50 to 64 years, 64 years).
The factors related to primary colorectal cancer, such as
its site (colon or rectum), were reported in 33 of 51, stage in
20 of 51, and tumor differentiation in 9 of 51. The time
interval between the primary resection and the appearance of
metastases (commonly but erroneously referred to as the
disease-free interval) was indicated in some way in 29 of 51.
The status with regard to present or previously resected
hepatic metastases was given in 38 of 51.
Carcinoembryonic antigen was reported in 19 of 51
but very variably, often categorized descriptively (high,
low, and normal) but with various cutoff values. An
indication of the number of metastases, at least whether
single or multiple, was given in 40 of 51 but in a wide
range of formats. Data on clearance of cancer at the
resection margin were given in 26 of 51.
The 5-year survival after metastasectomy was reported
in most of the articles (47 of 51). This seems to be the favored
way of reporting on survival, whereas mean and median
survivals were less frequently reported. It should be noted
that until all patients have died, the mean cannot be calcu-
lated, and this is one reason for preferring median because it
is defined when 50% of patients have died and cannot change
thereafter. However, median survival data cannot be amal-
gamated. Morbidity was scantily reported, and no reports
dealt with long-term functional status or lung function.
DISCUSSION
More than 100 years ago, the British surgeon, Hey
Groves, made “A plea for a uniform registration of oper-
ation results.”8 (Fig. 2) He wrote “. . . one fact is abun-
dantly clear from all medical literature and that is that
these statistics are employed by all writers to summarize
their results or to compare them with those of others.” He
goes on to say “But when the method of the compilation of
the figures relating to operation is examined, is it not
usually found to be very inadequate?” A century later, the
same view was taken independently by Simmonds et al,
Pfannschmidt et al, and Fiorentino et al4 – 6 in their attempts
to compile data from surgical reports. Because follow-up
studies are the commonest form of surgical evidence on
offer, this failure merits attention. Cardiothoracic surgeons
are aware of the need for uniform standards of reporting,
and there is a well-established practice in standardized
reporting of heart valves.9 –11 Stimulated no doubt by
competition from nonsurgical interventions, guidance has
recently extended to the descending thoracic aorta.12 To
our knowledge, there is no agreed standardization of re-
porting of surgical series in cancer.
Ideally, an analyst would like individual patient-
level data, and then data could be pooled and analyzed
with much larger numbers and thus more robust conclu-
sions. These patient-level data cannot realistically be pub-
lished but might be available on request or deposited on
the journal web site. However, the requirements for ano-
nymity are stringent, because there might well be sufficient
elements in anonymized data to identify the individual. If
dates of birth are recorded, together with the primary and
the subsequent operations, these will narrow down the
possible patients and may be unique identifiers.
TABLE 1. Data Items Looked for in Follow-Up Studies of
Pulmonary Metastasectomy for Colorectal Cancer
The nature of the clinical data reported
Prospective/retrospective
Start and end dates
Any comparison group
Information regarding the patient group
Age
Sex ratio
The colorectal cancer
Site
Stage
Histology
Hepatic metastases present or previously resected
The nature and effects of the pulmonary metastatic disease
Number
Size
Carcinoma embryonic antigen
Symptoms
The metastasectomy operation
First or repeat pulmonary metastasectomy
Thoracotomy or VATS
Unilateral, bilateral, or staged
Pathologic findings
R0/R1
Mediastinal lympadenopathy
Outcome
Perioperative mortality
Morbidity
Survival statistics
Symptoms
Pulmonary function
VATS, video-assisted thoracic surgery.
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The inconsistency in reporting data severely hampers
attempts at quantitative synthesis for both statisticians and
mathematical modelers. Although the many reports in the
literature are evidence of great efforts on the part of
clinicians to report on their case series, the variety and
differences in the way of reporting make any quantitative
analysis of the data an arduous task. In the course of the
data collation and analysis, the authors of the systematic
reviews found that data have not been reported consis-
tently. The same operative and cancer characteristics are
not reported in all articles. Some, such as histology,
margins of resection, or size of lesions, are so sparsely
reported, so that no useful inference can be drawn from
them. Others such as interoperative period and age, while
more consistently reported, are reported in different ways,
so that not all the information can be used for analysis.
Ideally, data should be in a form where mathematically
robust calculations can be performed for all articles reporting
series of pulmonary metastasectomy for colorectal cancer, so
that they can be amalgamated in a meta-analysis. Dichoto-
mous or categorical data (eg, sex, cancer stage, and cancer
site) can readily be amalgamated to compile a larger dataset.
If the denominator is provided, counts can be derived from
percentages. Statistical tests for heterogeneity would of
course be needed.
Age and tumor size are variables, and weighted
averages can be constructed from data supplied as mean
and SD, provided N is known. It is customary in surgical
reporting to use the median rather than the mean, with
some indicator of distribution, such as the extreme or
interquartile range. The median is popular for good rea-
sons. It describes skewed data better and has the advantage
that it is stable after the (N/2)th event has occurred.
However, medians cannot be amalgamated.
Apart from conventional data amalgamation, such as
meta-analysis, sufficient data in a range of forms might allow
a creative mathematical modeler to draw some inferences on
which to set hypotheses or to set upper or lower likely
bounds. Otherwise, although not adequate for any of mathe-
matical uses, the data at the very least should be in a form
where a clinician can gain a general impression that the cases
being described are or are not comparable with his or her own
practice. From the experience of the analysis of pulmonary
metastasectomy series in colorectal cancer, we conclude that
a standard way of reporting data on cancer series in general
not only will allow for a quantitative analysis of the data but
also can guide clinicians on selecting the most useful data to
FIGURE 1. Availability of data in the 51 articles for use in a quantitative synthesis.6 Each vertical column represents an article,
and if the data element on the left is included, this is indicated by a bar. The articles are ranked from left to right according
to the number of elements present. The numbers in the top row are citations in the original article.
FIGURE 2. The opening words of an article in the BMJ
(1908).8
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report on. A suggestion as to how such a check list might
appear is provided in Table 2.
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TABLE 2. A Proposed Template from Which Cancer Type Specific Reporting Forms Might Be Derived
The patient demographics
Sex N male N female Ratio
Age Mean SD Median Range
The series
Era Start date End date
Study type Follow-up Prospective Registry
Comparison group RCT Historical Cancer registry None
The cancer
Primary organ (or case mix): example Colon Rectum
Stage of the primary TNM Other standard
Histology (categorization appropriate to the
cancer) example
Differentiation Squamous carcinoma/
adenocarcinoma
Patients with cancer other than pulmonary
metastases
N
The pulmonary metastases
Number Solitary Multiple
Tumor markers by standard cutoff values Normal Elevated High
Distribution Unilateral Bilateral
Size (best appropriate summary according to
disease type)
Surgery
Approach VATS Thoracotomy Median sternotomy
Technique Wedge Laser Anatomical
Lymphatic dissection None Sampling Adenectomy
Sequence First Second Subsequent
Pathology
Margins R0 R1
Nodes Negative Positive
Outcome
Perioperative mortality N
Morbidity Early Late
Survival Median 5 yr 10 yr
Quality of Life (change)
Respiratory function (change)
TNM, tumor-node-metastasis staging; RCT, randomized controlled trial; VATS, video-assisted thoracic surgery.
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